Antigen testing: Addressing the critical need for rapid and sensitive COVID-19 testing
From its expedited development to its far-reaching adoption, COVID-19 antigen testing is helping students and workforces safely return to daily life
From its expedited development to its far-reaching adoption, COVID-19 antigen testing is helping students and workforces safely return to daily life
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D
Company’s RT-PCR kits and workflow solutions will continue to safeguard capacity for NHS Test and Trace laboratory
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
New findings pave way to potentially improved assessment of measurable residual disease in AML patients
The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes
Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min
Dr. Boye Schnack Nielsen shares tips for running successful in situ hybridization assays as he provides insights on how RNA detection methods have evolved over time
Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
Learn how COVID-19 serology testing may inform long-term vaccination strategy and influence short-term prioritization and delivery
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology
Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated